|
LSTA Lisata Therapeutics Inc 320017 |
| Balance Sheet |
|
Current Assets
|
34,578,000 |
|
Assets
|
35,002,000 |
|
Current Liabilities
|
5,613,000 |
|
Liabilities
|
5,685,000 |
|
Equity
|
29,317,000 |
|
Shares Out
|
8,320,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-19,356,000 |
|
Investing Cash Flow
|
13,233,000 |
| Market Analysis |
Market Cap
|
25,166,793 |
|
Price
|
2.25 |
|
BVPS
|
3.52 |
|
PB
|
0.67 |
|
EPS
|
-2.56 |
|
PS
|
6.29 |
|
FCF
|
-6,123,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LSTA documents filed with the SEC.
LSTA Filings
Clear
